Losartan: lessons learned from the RENAAL study.

about

Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats.

P2860

Q51785382-54D74241-4300-441E-AFD0-D0A4AEDBDBFD

P2860

Losartan: lessons learned from the RENAAL study.

Item

http://www.wikidata.org/entity/Q36428522

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

Losartan: lessons learned from the RENAAL study.

@ast

Losartan: lessons learned from the RENAAL study.

@en

type

Item

label

Losartan: lessons learned from the RENAAL study.

@ast

Losartan: lessons learned from the RENAAL study.

@en

prefLabel

Losartan: lessons learned from the RENAAL study.

@ast

Losartan: lessons learned from the RENAAL study.

@en

P1476

Losartan: lessons learned from the RENAAL study.

@en

P2093

Barry M Brenner

http://www.w3.org/2001/XMLSchema#string

Paulette A Lyle

http://www.w3.org/2001/XMLSchema#string

Shahnaz Shahinfar

http://www.w3.org/2001/XMLSchema#string

William F Keane

http://www.w3.org/2001/XMLSchema#string

Zhongxin Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study.

Angiotensin II: a pivotal factor in the progression of renal diseases.

Losartan reduces the burden and cost of ESRD: public health implications from the RENAAL study for the European Union.

2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Dialysis delayed is death prevented: a clinical perspective on the RENAAL study.

Losartan and the United States costs of end-stage renal disease by baseline albuminuria in patients with type 2 diabetes and nephropathy.

P304

623-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.7.5.623

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16553578

http://www.w3.org/2001/XMLSchema#string

Losartan: lessons learned from the RENAAL study.

about

P2860

P2860

Losartan: lessons learned from the RENAAL study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698